Home Glaciers Move Mountains for Multiple Myeloma Program to roam Alaska’s Kenai Peninsula, glaciers, coastline, and wildlife in August

Move Mountains for Multiple Myeloma Program to roam Alaska’s Kenai Peninsula, glaciers, coastline, and wildlife in August


CRANBURY, NJ, Aug 2, 2021 – As part of a Moving Mountains for Multiple Myeloma® (MM4MM) fundraising effort, a 12-person team will take an epic journey through the Alaska-Kenai Peninsula from 16-21 August, 2021.

MM4MM is a joint initiative between the Multiple Myeloma Research Foundation (MMRF) and CURE Media Group and is sponsored by Sanofi Genzyme. The coming ascension includes multiple myeloma patients, caregivers, friends and family members.

“This program is truly such a powerful and life-changing experience for every hiker, and we look forward to continuing our support to help raise awareness and raise vital funds for multiple myeloma research,” said Mike Hennessy Jr. ., President and CEO of MJH Life Sciences ™, parent company of CURE Media Group.

Since MM4MM began its first ascent in 2016, the program has raised over $ 3 million. All profits raised go directly to the MMRF. A pioneer in precision medicine, MMRF seeks to find a cure for all patients with multiple myeloma by relentlessly pursuing innovations that drive the development of precision cancer treatments.

“As a patient-focused organization, MMRF stands alongside those fighting multiple myeloma – patients, families, physicians, researchers and our partners. This team represents a microcosm of our community and demonstrates that together we can move mountains in our shared search for a cure for every patient, ”said Michael Andreini, President and CEO of the Multiple Myeloma Research Foundation. “This Sanofi-sponsored effort helps us continue our mission of a world without multiple myeloma.”

The MM4MM Alaska team will include five patients with multiple myeloma:

  • Lynn Cella has a personal connection to multiple myeloma, which began in early 2014, when she was diagnosed with the difficult disease. Today, she is grateful to say that she is in remission and excited to join her team in Alaska in August to show that she is resilient and will continue to live my life to the fullest.
  • JP Kealy began her journey with multiple myeloma in 2014. As a husband and father of four, Kealy never thought he would face cancer. This will be Kealy’s third MM4MM ride, and he’s excited to be a part of it. He took the opportunity to meet new patients, doctors and relatives of patients with MM.
  • King Terry was diagnosed with latent multiple myeloma in February 2019. When Terry was first diagnosed she was devastated, but her faith and the support of her family and friends got her through some tough times as she ‘she was struggling to overcome this illness. Terry is still considered brooding, with no signs of illness and is currently not receiving any medication.
  • Michael Mankowich, in February 2017, was faced with the challenge of learning he had cancer. Two years later, he is managing his daily life with multiple myeloma, with the incredible support of his wife, Kathleen, and daughter, Mary, as well as medical staff at Memorial Sloan Kettering Cancer Center.
  • Suzanne Wolfrom was diagnosed with multiple myeloma three years ago when she had just retired. As a breast cancer survivor, Wolfrom once battled cancer. The discovery of new therapies has helped her nurture renewed hope and she is grateful to prepare for the trip to Alaska in the hopes of helping MMRF achieve its goal of giving hope to cancer victims.

“We are thrilled and proud to support Moving Mountains for Multiple Myeloma,” said John Wilson, Director of Hematology-Oncology Marketing at Sanofi Genzyme. “This initiative is a great way to raise awareness and foster greater connectivity with the multiple myeloma and blood cancer patient community. We are truly moved and inspired by everyone involved in this program.

To learn more about Moving Mountains for Multiple Myeloma® and to donate to multiple myeloma research, click here.

For more information on the Multiple Myeloma Research Foundation, click here.

For more information on CURE Media Group, click here.